{
  "ptid_time": "130_S_4294_2015-12-16",
  "img_path": "/data/qiuhui/data/adni/images/130_S_4294/2015-12-16/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 3,831 mm³, 46.2% below the reference mean. With a Z-score of -4.23 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 79.2 years. Gender is Female. Education: 16 years. MMSE: 25.0. MoCA: 21.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.32 SUVR (moderate elevated); Amyloid beta: 469.00 pg/mL (mild reduced); Total tau: 285.80 pg/mL (normal ); Phosphorylated tau: 26.74 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is severely reduced (46.2% below mean, Z-score -4.23), indicating significant neurodegeneration. Despite relatively preserved cognition (MMSE 25, MoCA 21), the structural damage and elevated AV45 (amyloid-PET) suggest Alzheimer’s pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease** (biomarker-supported).  \n\n**Confidence:** **High** (due to clear hippocampal atrophy and amyloid positivity, despite borderline cognitive scores).  \n\n*Note:* The MMSE/MoCA scores are near the dementia threshold, but the absence of clear functional decline (if confirmed clinically) keeps this in the MCI range. Progression to dementia is likely imminent.",
  "timestamp": "2025-07-26T14:39:40.439163"
}